Product Name |
Rupatadine Impurity B |
Alternate Names |
Rupatadine Impurities, Impurities of Rupatadine |
CAT No. |
CS-O-32665
|
CAS No. |
156523-04-5 |
Category |
Impurities |
Stock |
IN-Stock
|
Mol. Wt. |
429.94 g/mol |
Mol. For. |
C₂₆H₂₄ClN₃O
|
Hazardous |
This is not a Hazardous Compound
|
COA |
View Sample COA
|
MSDS |
View Sample MSDS
|
Parent API |
Rupatadine |
Purity |
95% |
Therapeutic |
Antihistamine |
Smileys |
ClC1=CC=C2C(CCC3=C(N=CC=C3)/C2=C4CCN(C(C5=CN=CC(C)=C5)=O)CC\4)=C1 |
Controlled |
No |
Shipping |
Free for purchase above 1000$ |
Delivery |
In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
Return |
Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
Ordering |
Place your order online or by email sales@clearsynth.com |
If you find a better price anywhere else we guarantee Price match.
Rupatadine Impurity B is a chemical compound that is used in the development and testing of pharmaceutical products. It is a byproduct or impurity that is produced during the synthesis of rupatadine, which is a medication used to treat allergic rhinitis and urticaria. Rupatadine Impurity B is an important compound that is used in the quality control of rupatadine due to its potential impact on the safety and efficacy of the drug.
Chemically, Rupatadine Impurity B is a member of the phenylpiperazine class of compounds. It has a molecular weight of 318.42 g/mol and a molecular formula of C19H20N2O2. The compound is known to have moderate to high solubility in common organic solvents such as methanol, ethanol, and acetone. However, it is sparingly soluble in water, which can make its isolation and purification challenging.
The usage of Rupatadine Impurity B is primarily in the pharmaceutical industry, where it is used as a reference standard for the analysis of rupatadine in drug formulations. It is also used in the development of analytical methods to quantify rupatadine in biological samples such as plasma and urine. The compound is essential in ensuring the safety and efficacy of rupatadine-based medications, as it can help identify potential impurities or contaminants that may affect the quality of the drug product.